Lakefront Biotherapeutics NV Sustainability Reports

The company is a clinical-stage biotechnology enterprise that develops medicines for patients with serious diseases in areas of unmet medical need, particularly focusing on oncology and immunology programs.

Sector: Professional & technical services

Country: Belgium

Exchange: Euronext Amsterdam

LEI: 549300QKJ78IY0IOV655

FIGI: BBG001SGN0C2

31 reports from 2006 to 2025

• Lakefront Biotherapeutics NV 2025 Annual Accounts and Other Documents to Be Filed in Accordance with the Belgian Companies and Associations Code
• Lakefront Biotherapeutics NV 2025 Annual Report
• Lakefront Biotherapeutics NV 2025 Annual Report
• Lakefront Biotherapeutics NV 2024 Annual Report
• Lakefront Biotherapeutics NV 2024 Sustainability Statements